Abstract:Background: Pneumonia is an infection of the pulmonary parenchyma, causing significant morbidity and mortality. Inflammation potentiates hypoalbuminemia. CRP is an acute phase reactant produced by the liver in response to inflammation, which depends on severity of illness. Serum albumin concentration as a negative acute phase reactant, changes with change in CRP(C-reactive protein) value. Objectives: To study the prognostic significance of commonly used biomarkers serum Albumin level and C - reactive protein in hospitalized patients with Community Acquired Pneumonia. Methodology: The prospective study was conducted in a hospital affiliated to Vijayanagara Institute of Medical Science, Ballari. Patients with signs and symptoms of CAP were hospitalized based on a CURB-65 score. After informed consent, all relevant data was collected. Clinical examination and laboratory parameters i.e. Serum albumin & C - reactive protein levels on day 1, 3 & 7/discharge were carried out. The values of serum albumin & C - reactive protein were analyzed with the clinical profile and outcome in these study groups. Results: In our study, CAP was more commonly seen among the age group of 61-70 yrs (27%). COPD was a major associated co-morbidity (50%) and smoking was an important risk factor (70%). The majority had a CURB 65 score of >3-5 on admission (64%). Out of 50 patients, 26% of them had severe hypoalbuminemia (<2.5 mg/dl) and 58% of them had mild hypoalbuminemia (2.5-3.5 mg/dl) on day 1 of admission. When serum albumin levels at the time of admission were analyzed for the time of discharge, there was significant change (P=0.025) noted, i.e an increase in serum albumin levels were seen in all patients who had clinical signs of resolution. 38% of patients had serum CRP levels 200 mg/l. There was decrease in CRP level at the time of discharge (p=0.001). Serum Albumin levels and CRP levels showed significant change from day 1 to the day of discharge (p=0.025 and P=<0.001) respectively. ICU requirement, need for mechanical ventilation and other outcomes correlated well with serum albumin levels (p=0.021, p=0.004, p=0.003 respectively). Conclusion: Our study showed a history of smoking, COPD and hypoalbuminemia at presentation were major risk factors present for CAP. Patients with severe hypoalbuminemia had high morbidity and mortality in the form of ICU requirement, need for mechanical ventilation, complications and death. CRP serves as an important marker of inflammation whose series levels reduce significantly with cure / resolution of pneumonia. Thus, serum albumin levels and C reactive protein can be used as a prognostic biomarker in community acquired pneumonia.

Serum Albumin And C-reactive Protein as Prognostic Biomarkers in Hospitalised Patients with Community Acquired Pneumonia

The Prognostic Value of Serum Albumin Levels and Respiratory Rate for Community-Acquired Pneumonia: A Prospective, Multi-Center Study.

Serum Procalcitonin, White Blood Cell and Hypersensitive C-reactive Protein Combined with Age Established a New Prediction Model in Predicting ICU Admission in Adult Community-Acquired Pneumonia (CAP) Patients.

Neutrophil-to-Lymphocyte Ratio Improves the Accuracy and Sensitivity of Pneumonia Severity Index in Predicting 30-Day Mortality of CAP Patients

Significance of Detecting Serum C-reactive Protein, in Evaluating Community-Acquired Pneumonia

The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia

To Study Role of Serial Serum Albumin Estimation as Prognostic Marker in Critically Ill Patients

Role of C-reactive Protein as an Indicator for Determining the Outcome of Sepsis

Correlation of inflammatory and cardiovascular biomarkers with pneumonia severity scores

Study of Inflammatory Markers in Chronic Obstructive Pulmonary Disease

C-Reactive Protein/Albumin Ratio Predicts 90-Day Mortality of Septic Patients

Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia

The Relationship Between Serum Albumin Levels and Sepsis in Patients Admitted to a Tertiary Care Center in India

Serum levels of immunoglobulins and severity of community-acquired pneumonia

The prognostic value of C-reactive protein for children with pneumonia

Serum IL-27 Predicts the Severity and Prognosis in Patients with Community-Acquired Pneumonia: a Prospective Cohort Study

Impact of Serum Biomarkers and Clinical Factors on Intensive Care Unit Mortality and 6-Month Outcome in Relatively Healthy Patients with Severe Pneumonia and Acute Respiratory Distress Syndrome.

The role of cystatin C in evaluating the severity and predicting the hospital mortality of patients with community-acquired pneumonia

Prognostic significance of eosinophil-to-platelet ratio and C-reactive protein in predicting adverse events during acute exacerbations of chronic obstructive pulmonary disease: A comprehensive observational study

Serum activin A as a prognostic biomarker for community acquired pneumonia

Prognostic values of CURB-65 score and inflammatory factors for hospitalized community-acquired pneumonia patients